# T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders

> **NCT00176826** · PHASE2,PHASE3 · TERMINATED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 22 (actual)

## Conditions studied

- Hemophagocytic Lymphohistiocytosis
- X-Linked Lymphoproliferative Disorders
- Chediak-Higashi Syndrome
- Griscelli Syndrome
- Immunologic Diseases
- Langerhans-Cell Histiocytosis
- Hematologic Diseases

## Interventions

- **PROCEDURE:** Stem Cell Transplant
- **DRUG:** Myeloablative conditioning regimen

## Key facts

- **NCT ID:** NCT00176826
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-09
- **Primary completion:** 2012-08
- **Final completion:** 2015-08
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Replaced by another protocol
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00176826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00176826, "T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00176826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*